Leo Miller, Contributing Author at MarketBeat Articles by Leo Miller - Page 5September 4, 2024 8:10 AM ETTop 3 Stocks to Outperform the S&P 500 in a DownturnLeo MillerCheck out these three stocks that have outperformed big in past bear markets. Their business have inherent advantages the success in a downturn.NYSE:GISNYSE:OHINYSE:WTRGRead Top 3 Stocks to Outperform the S&P 500 in a DownturnSeptember 1, 2024 5:00 AM ETDon’t Overlook Campbell Soup: Here’s What Could Drive Its StockLeo MillerCampbell Soup has been a steady performer in 2024. The addition of a new market-leading and fast-growing product is going a long way.NYSEARCA:XLPNASDAQ:CPBRead Don’t Overlook Campbell Soup: Here’s What Could Drive Its StockAugust 31, 2024 5:15 AM ETBirkenstock’s Sudden Slide—Why It Might Be Your Next Big WinLeo MillerBirkenstock's shares went down hard as the priced-for-perfection stock failed to live up to expectations. However, long-term opportunity remains.NYSEARCA:XLYNYSE:SKXNASDAQ:CROXRead Birkenstock’s Sudden Slide—Why It Might Be Your Next Big WinAugust 31, 2024 5:00 AM ETWhy Dell Can Continue Winning in AI and BeyondLeo MillerDell Technologies is transitioning its business to cater to AI-demand. Its strong pipeline of deals is a good sign for future demand.NYSEARCA:XLKNYSE:DELLRead Why Dell Can Continue Winning in AI and BeyondAugust 30, 2024 10:00 AM ETWhy Analysts Are Bullish on Marvell Despite Sector WeaknessLeo MillerMarvell Technologies is seeing rapid growth in its data center business, but significant other challenges remain for the firm.NASDAQ:SOXQNASDAQ:NVDANASDAQ:AVGORead Why Analysts Are Bullish on Marvell Despite Sector WeaknessAugust 30, 2024 5:45 AM ETPolestar Lives to Fight Another Day After Q2 EarningsLeo MillerPolestar Automotive showed improvement in its latest earnings release, but it needs to show sustained progress. The company's new product might help.OTCMKTS:GELYYOTCMKTS:VLVLYNYSE:FRead Polestar Lives to Fight Another Day After Q2 EarningsAugust 30, 2024 5:15 AM ETApplied Digital's Stock Recovery: Analysts Forecast Strong UpsideLeo MillerApplied Digital shares are down 56% since its IPO but have a potential 110% upside. It now focuses on AI, but high energy costs are hurting margins.NASDAQ:MARANASDAQ:APLDRead Applied Digital's Stock Recovery: Analysts Forecast Strong UpsideAugust 29, 2024 1:18 PM ETAbercrombie & Fitch Stock Surges 87%: What’s Driving the Growth?Leo MillerAbercrombie & Fitch has been one of the biggest turnaround stock stories in recent years. It posted impressive results in Q2 but markets were still unhappy.NYSE:CVNANYSE:NKETSE:LLLRead Abercrombie & Fitch Stock Surges 87%: What’s Driving the Growth?August 29, 2024 8:32 AM ETAffirm Shows Buy-Now-Pay-Later Is Here to Stay in Latest ResultsLeo MillerAffirm buy-now-pay-later business model was once in question. Although not out of the woods yet, its recent results are assuaging fears.NASDAQ:AAPLNYSE:CNYSE:SYFRead Affirm Shows Buy-Now-Pay-Later Is Here to Stay in Latest ResultsAugust 29, 2024 8:02 AM ETExpanding Its "Partner Ecosystem" Could Reignite Growth at OKTA Leo MillerOKTA is moving closer to non-adjusted profitability, but revenues continue to slow. Its partner ecosystem may be able to reinvigorate growth.NYSEARCA:XLKNASDAQ:OKTARead Expanding Its "Partner Ecosystem" Could Reignite Growth at OKTA August 29, 2024 5:30 AM ETBath & Body Works Rebound Ahead? Why Analysts Remain OptimisticLeo MillerBath & Body Works continued to fall after Q2 earnings. It's hard to find a reason for optimism, but the company could capitalize on its loyal customer base.NYSEARCA:XLYNYSE:CNYSE:BCSRead Bath & Body Works Rebound Ahead? Why Analysts Remain OptimisticAugust 23, 2024 6:50 AM ETBiotech Stock Soars 60% in 2024: Cathie Wood’s Bold InvestmentLeo MillerTempus AI is a hot healthcare stock that investors should be aware of. It is using AI to pursue "precision medicine", especially in cancer research.NASDAQ:PSNLNASDAQ:TEMRead Biotech Stock Soars 60% in 2024: Cathie Wood’s Bold InvestmentAugust 23, 2024 5:30 AM ETSynopsys: Looking to Stay Ahead of Industry Trends after Solid Q3Leo MillerSynopsys beat estimates on adjusted earnings per share and revenue. Answers to questions in the earnings call also gave positive signals.NASDAQ:SOXQNASDAQ:CDNSOTCMKTS:SMAWFRead Synopsys: Looking to Stay Ahead of Industry Trends after Solid Q3August 22, 2024 10:11 AM ETUrban Outfitters Stock Dips: Can a Gen-Z Strategy Boost Sales?Leo MillerUrban Outfitters beat on adjusted EPS and revenue in the quarter. However, further weakness was seen in its namesake stores, sending shares down.NYSE:NKENASDAQ:LULUNYSEARCA:XLYRead Urban Outfitters Stock Dips: Can a Gen-Z Strategy Boost Sales?August 22, 2024 9:31 AM ETToll Brothers Stock Up on Q3 Beat: Luxury Homes Drive GrowthLeo MillerToll Brothers posted better-than-expected adjusted earnings per share in its latest release. The firm faces multiple headwinds and tailwinds.NYSE:TOLNYSE:LENNYSE:DHIRead Toll Brothers Stock Up on Q3 Beat: Luxury Homes Drive GrowthAugust 21, 2024 6:55 AM ETIs AMD Closing the Gap with NVIDIA After Its Recent Acquisition?Leo MillerAdvanced Micro Devices recently announced they are acquiring ZT Systems to help them compete in the data center market against Nvidia. NASDAQ:AMDNASDAQ:NVDARead Is AMD Closing the Gap with NVIDIA After Its Recent Acquisition?August 21, 2024 6:15 AM ETIs Lam Research the Semiconductor Stock You’ve Been Overlooking?Leo MillerLAM Research is a key contributor to the semiconductor industry value chain. In faces several tailwinds and headwinds that investors should be aware of.NASDAQ:LRCXNASDAQ:ASMLNASDAQ:AMATRead Is Lam Research the Semiconductor Stock You’ve Been Overlooking?August 21, 2024 5:00 AM ETThe First Half of 2025 Will Be a Massive Test for AST SpaceMobileLeo MillerAST SpaceMobile recently announced it plans to launch its first five satellites in September, sending shares up massively.NASDAQ:ASTSNYSE:TNYSE:VZRead The First Half of 2025 Will Be a Massive Test for AST SpaceMobileAugust 20, 2024 7:29 AM ETGeoVax Labs: Is This Micro-Cap Biotech Stock a Boom or a Bust?Leo MillerGeoVax Labs has seen its shares rise enormously over the past few days after an announcement from the World Health Organization relevant to one of its drugs.NASDAQ:GOVXNASDAQ:SIGANASDAQ:MRNARead GeoVax Labs: Is This Micro-Cap Biotech Stock a Boom or a Bust?August 19, 2024 6:00 AM ETThis Early-Stage Biotech Stock Is Up 400% — Should You Buy Now?Leo MillerAvidity Biosciences' stock has performed incredibly well in 2024. Its Duchenne muscular dystrophy drug is showing strong results in trials.NASDAQ:RNANASDAQ:SRPTRead This Early-Stage Biotech Stock Is Up 400% — Should You Buy Now?August 19, 2024 5:00 AM ETThe Worst May Be Over for Cisco After Beating Estimates in Q4Leo MillerCisco Systems posted better-than-expected results in its fiscal Q4 earnings release. There are some signs for optimism even as the firm lays off thousands.NASDAQ:INTCNASDAQ:CSCONYSE:ANETRead The Worst May Be Over for Cisco After Beating Estimates in Q4August 18, 2024 5:05 AM ETThis Small Cap Wealth Management Stock Could Provide Big ReturnsLeo MillerAlTi Global is poised to benefit from several tailwinds in the wealth management industry. One Wall Street analyst sees significant upside.NASDAQ:ALTINYSE:JPMNYSE:UBSRead This Small Cap Wealth Management Stock Could Provide Big ReturnsAugust 17, 2024 5:15 AM ETBumble's Valuation Hits an All-Time Low, Can Its Fortunes Change?Leo MillerBumble's now trades at the lowest forward valuation in its history after shares spiraled following its latest earnings release.NASDAQ:BMBLNASDAQ:MTCHRead Bumble's Valuation Hits an All-Time Low, Can Its Fortunes Change?August 16, 2024 5:45 AM ETUBS Posts Fantastic Q2 Results, But Regulatory Changes Loom LargeLeo MillerUBS's integration with Credit Suisse is progressing better than many expected. This was on display as the firm performed above expectations in Q2.NYSE:UBSOTCMKTS:JBAXYNASDAQ:EUFNRead UBS Posts Fantastic Q2 Results, But Regulatory Changes Loom Large Page 5 of 7 « Most Recent‹ More Recent1234567 Earlier › Earliest » Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
